Skip to main navigation
Skip to search
Skip to main content
University of Edinburgh Research Explorer Home
Help & FAQ
Home
Research output
Profiles
Research Units
Projects
Datasets
Prizes
Activities
Press / Media
Equipment
Search by expertise, name or affiliation
Treatment of children under 5 yrs old:investigation of accessibility, efficacy and immunology of praziquantel treatment
Mutapi, Francisca
(Principal Investigator)
School of Biological Sciences
Overview
Fingerprint
Research output
(1)
Project Details
Status
Finished
Effective start/end date
1/03/09
→
28/02/10
Funding
Non-EU other:
£17,564.00
View all
View less
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Mass Drug Administration
Medicine & Life Sciences
100%
Praziquantel
Medicine & Life Sciences
90%
Schistosomiasis
Medicine & Life Sciences
80%
Parasites
Medicine & Life Sciences
56%
Epidemiology
Medicine & Life Sciences
35%
Schistosoma
Medicine & Life Sciences
31%
Neglected Diseases
Medicine & Life Sciences
30%
Helminths
Medicine & Life Sciences
27%
Research output
Research output per year
2017
2017
2017
1
Review article
Research output per year
Research output per year
Human schistosomiasis in the post Mass Drug Administration (MDA) era
Mutapi, F.
,
Maizels, R.
,
Fenwick, A.
&
Woolhouse, M.
,
1 Feb 2017
,
In:
The Lancet Infectious Diseases.
17
,
2
,
p. E42-E48
Research output
:
Contribution to journal
›
Review article
›
peer-review
Open Access
File
Mass Drug Administration
100%
Praziquantel
90%
Schistosomiasis
80%
Parasites
56%
Epidemiology
35%